Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)

NCT02093260 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Vaccine

Sponsor

PT Bio Farma